Clinical

Dataset Information

0

KX2-391 in Treating Patients With Advanced Solid Tumors or Lymphoma That Did Not Respond to Treatment

ABSTRACT: RATIONALE: KX2-391 may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. PURPOSE: This phase I trial is studying the side effects and best dose of KX2-391 in treating patients with advanced solid tumors or lymphoma that did not respond to treatment.

DISEASE(S): Lymphoproliferative Disorders,Lymphoproliferative Disorder,Small Intestine Cancer,Angioimmunoblastic T-cell Lymphoma,Lymphoma,Intestinal Neoplasms,Unspecified Adult Solid Tumor, Protocol Specific

PROVIDER: 2052967 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Json Xml

Similar Datasets

Clinical Imetelstat Sodium in Treating Young Patients With Refractory or Recurrent Solid Tumors or Lymphoma
| 2100536 | ecrin-mdr-crc
Clinical Alisertib in Combination With Vorinostat in Treating Patients With Relapsed or Recurrent Hodgkin Lymphoma, B-Cell Non-Hodgkin Lymphoma, or Peripheral T-Cell Lymphoma
| 2123001 | ecrin-mdr-crc
Clinical Vorinostat After Stem Cell Transplant in Treating Patients With High-Risk Lymphoma
| 2046609 | ecrin-mdr-crc
Clinical Vorinostat and Lenalidomide in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-Hodgkin Lymphoma
| 2088557 | ecrin-mdr-crc
Clinical Everolimus in Treating Patients With Advanced or Metastatic Colorectal Cancer That Did Not Respond to Previous Therapy
| 2033744 | ecrin-mdr-crc
Clinical Panobinostat in Treating Patients With Relapsed or Refractory Non-Hodgkin Lymphoma
| 2099626 | ecrin-mdr-crc
Clinical Ibrutinib in Treating Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma in Patients With HIV Infection
| 2164362 | ecrin-mdr-crc
Clinical Rituximab, Romidepsin, and Lenalidomide in Treating Patients With Recurrent or Refractory B-cell Non-Hodgkin Lymphoma
| 2177542 | ecrin-mdr-crc
Clinical Vorinostat in Treating Patients With Metastatic or Unresectable Solid Tumors or Lymphoma and Liver Dysfunction
| 2041970 | ecrin-mdr-crc
Clinical MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma
| 2006457 | ecrin-mdr-crc